000 | 00908 a2200277 4500 | ||
---|---|---|---|
005 | 20250516131455.0 | ||
264 | 0 | _c20130123 | |
008 | 201301s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMp1213134 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKlein, Harvey G | |
245 | 0 | 0 |
_aShould blood be an essential medicine? _h[electronic resource] |
260 |
_bThe New England journal of medicine _cJan 2013 |
||
300 |
_a199-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBlood |
650 | 0 | 4 | _aBlood Transfusion |
650 | 0 | 4 | _aDrugs, Essential |
650 | 0 | 4 | _aErythrocytes |
650 | 0 | 4 | _aGovernment Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInsurance Coverage |
773 | 0 |
_tThe New England journal of medicine _gvol. 368 _gno. 3 _gp. 199-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMp1213134 _zAvailable from publisher's website |
999 |
_c22423346 _d22423346 |